The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Professional Services Scientific, Architectural And Engineering Technical Activities Scientific Research And Development 72.1 - Research and experimental development on natural sciences and engineering
120 jobs Number of planned job losses
Announcement Date
13 March 2012
Employment effect (start)
19 March 2012
Foreseen end date
Description
Forenap Pharma, a company specialized in research and development in neuroscience, will cut 120 jobs after having been put into liquidation on 14 March 2012. The Commercial Court of Colmar announced the liquidation of Forenap after the company had been placed into receivership two months ago.
According to the Works Council secretary, 25 years of know-how will disappear through the liquidation. 70 per cent of the dismissed employees are executives.
Eurofound (2012), Forenap Pharma, Bankruptcy in France, factsheet number 73269, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/73269.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
